-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. quarterly General and Administrative Expense history and growth rate from Q1 2024 to Q3 2025.
- Cyclacel Pharmaceuticals, Inc. General and Administrative Expense for the quarter ending September 30, 2025 was $1M, a 18.8% decline year-over-year.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)